'
Home / About / Einstein Care Partners ACO / Medicare Shared Savings ACO Public Reporting

Medicare Shared Savings ACO Public Reporting

Columns Layout = 2

ACO Name and Location

Einstein Care Partners, LLC
3300 Henry Avenue
Falls 2 Suite 601
Philadelphia, Pennsylvania 19129-1121

ACO Primary Contact

Name: Jason Aronovitz, DO
Email: Jason.Aronovitz@jefferson.edu

Organizational Information

ACO Participants:

ACO Participants ACO Participant in Joint Venture
Fornance Physician Services Inc No
Einstein Practice Plan Inc No
Einstein Community Health Associates, Inc. No

ACO Governing Body:

Member Last Name First Name Title/Position Member's
Voting Power
Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Aronovitz, DO Jason  ACO Executive 0 Other Einstein Care Partners, LLC
Nicholas, MD Angela Co-Chair 1 ACO Participant Representative Fornance Physician Services
Sivak, MD Steven Co-Chair 1 ACO Participant Representative Einstein Practice Plan, Inc.
Scaven, DO Christopher Member 1 ACO Participant Representative Einstein Community Health Associates
Behan, MD Katherine Member 1 Other Einstein Care Partners, LLC
Kaminetsky, DO Eric Member 1 ACO Participant Representative Kennedy Medical Group Practice, P.C.
Phakey, DO Vishal Member 1 ACO Participant Representative Kennedy Medical Group Practice, P.C.
May, DO David Member 1 ACO Participant Representative Kennedy Medical Group Practice, P.C.
Gettings, DO Matthew Member 1 ACO Participant Representative
Kennedy Medical Group Practice, P.C.
Lechter Lynne Member 1 Medicare Beneficiary Representative
Einstein Care Partners, LLC

Key ACO Clinical and Administrative Leadership:

Jason Aronovitz, DO - ACO Executive
Rupa Natarajan, MD - Medical Director
Amy Matchette - Compliance Officer
Tina Sokolowski - Quality Assurance/Improvement Officer

Associated Committees and Committee Leadership:

Committee Name Committee Leader Name and Position
Clinical Performance and Integration Committee Jason Aronovitz, DO (Co-Chairperson) and Tina Sokolowski (Co-Chairperson)
Membership and Nominating Committee Angela Nicholas, MD (Co-Chairperson) and Steven Sivak, MD (Co-Chairperson)
Compliance Committee Amy Matchette (Chairperson)

Types of ACO Participants, or Combinations of Participants, That Formed The ACO:

  • ACO professionals in a group practice arrangement
  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

Fourth Agreement Period

• Performance Year 2021: $0

Third Agreement Period

• Performance Year 2020: $6,273,203

Second Agreement Period

• Performance Year 2019: $0

First Agreement Period

• Performance Year 2018: $1,905,474

Shared Savings Distribution

Fourth Agreement Period

Performance Year 2021

  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A

Third Agreement Period

Performance Year 2020

  • Proportion invested in infrastructure: 10%
  • Proportion invested in redesigned care processes/resources: 10%
  • Proportion of distribution to ACO participants: 80%

Second Agreement Period

Performance Year 2019

  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A

First Agreement Period

Performance Year 2019

  • Proportion invested in infrastructure: 10%
  • Proportion invested in redesigned care processes/resources: 10%
  • Proportion of distribution to ACO participants: 80%

Quality Performance Results

2021 Quality Performance Results

Measure # Measure Name Eligible for Scoring Performance Rate 
ACO Mean
001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control
Y 19.56  12.46
134
Preventative Care and Screening: Screening for Depression and Follow-up Plan
N 79.37  74.38
236
Controlling High Blood Pressure
Y 65.07  74.87
318
Falls: Screening for Future Fall Risk
Y 89.68  87.03
110
Preventative Care and Screening: Influenza Immunization
Y 65.99  80.52
226
Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention
Y 54.29  80.97
113
Colorectal Cancer Screening
Y 68.74  73.63
112
Breast Cancer Screening
Y 76.48  75.11
438
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
N 85.74  84.24
370
Depression Remission at Twelve Months N 15.25  15.50
321 CAHPS for MIPS Y N/A  N/A
479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups
Y 0.1673  0.1540
MCC1 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)
Y 41.33  33.99
CAHPS-1 Getting Timely Care, Appointments, and Information
Y 77.62  84.67
CAHPS-2
How Well Providers Communicate
Y 96.17  93.56
CAHPS-3
Patient’s Rating of Provider
Y 93.34  92.19
CAHPS-4
Access to Specialists
N 73.65  78.8
CAHPS-5
Health Promotion and Education
Y 64  61.61
CAHPS-6
Shared Decision Making
Y 56.49  60.89
CAHPS-7
Health Status and Functional Status
N 72.5  71.78
CAHPS-8
Care Coordination
Y 84.2  85.66
CAHPS-9
Courteous and Helpful Office Staff
Y 89.21  91.88
CAHPS-11
Stewardship of Patient Resources Y 26.5  24.71

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

ACO Participation Waiver:

The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.

  • Parties to the arrangement: ACO and ACO Participants listed above
  • Date of arrangement: January 1, 2018
  • Items, services, goods, or facility provided: ACO provides administrative and analytic support to ACO Participants.
  • Date and nature of any amendments to the arrangement, if applicable: N/A

Download this information in a document (PDF) here.

 

Einstein Care Partners, LLC
Einstein Care Partners, LLC
© 2022 Einstein Healthcare Network. All rights reserved.